CN103954775B - A kind of method detecting biomacromolecule or microbial body - Google Patents
A kind of method detecting biomacromolecule or microbial body Download PDFInfo
- Publication number
- CN103954775B CN103954775B CN201410197209.1A CN201410197209A CN103954775B CN 103954775 B CN103954775 B CN 103954775B CN 201410197209 A CN201410197209 A CN 201410197209A CN 103954775 B CN103954775 B CN 103954775B
- Authority
- CN
- China
- Prior art keywords
- biomacromolecule
- aggregation
- concentration
- sample
- microbial body
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title claims abstract description 42
- 230000000813 microbial effect Effects 0.000 title claims abstract description 11
- 239000011324 bead Substances 0.000 claims abstract description 73
- 230000002776 aggregation Effects 0.000 claims abstract description 33
- 238000004220 aggregation Methods 0.000 claims abstract description 33
- 238000011534 incubation Methods 0.000 claims abstract description 6
- 102000004169 proteins and genes Human genes 0.000 claims description 14
- 108090000623 proteins and genes Proteins 0.000 claims description 14
- 241000700605 Viruses Species 0.000 claims description 8
- 230000000890 antigenic effect Effects 0.000 claims description 8
- 235000013305 food Nutrition 0.000 claims description 6
- 241000894006 Bacteria Species 0.000 claims description 5
- 241000233866 Fungi Species 0.000 claims description 5
- 150000004676 glycans Chemical class 0.000 claims description 3
- 102000039446 nucleic acids Human genes 0.000 claims description 3
- 108020004707 nucleic acids Proteins 0.000 claims description 3
- 150000007523 nucleic acids Chemical class 0.000 claims description 3
- 229920001282 polysaccharide Polymers 0.000 claims description 3
- 239000005017 polysaccharide Substances 0.000 claims description 3
- 230000035484 reaction time Effects 0.000 claims description 3
- 102000003886 Glycoproteins Human genes 0.000 claims description 2
- 108090000288 Glycoproteins Proteins 0.000 claims description 2
- 102000004895 Lipoproteins Human genes 0.000 claims description 2
- 108090001030 Lipoproteins Proteins 0.000 claims description 2
- 102000011931 Nucleoproteins Human genes 0.000 claims description 2
- 108010061100 Nucleoproteins Proteins 0.000 claims description 2
- 239000000090 biomarker Substances 0.000 claims description 2
- 244000005700 microbiome Species 0.000 abstract description 35
- 238000001514 detection method Methods 0.000 abstract description 23
- 229920002521 macromolecule Polymers 0.000 abstract description 15
- 238000007885 magnetic separation Methods 0.000 abstract description 12
- 239000002245 particle Substances 0.000 abstract description 11
- 238000012360 testing method Methods 0.000 abstract description 6
- 230000000007 visual effect Effects 0.000 abstract description 5
- 230000008569 process Effects 0.000 abstract description 2
- 239000000523 sample Substances 0.000 description 27
- 241000588724 Escherichia coli Species 0.000 description 12
- 238000010586 diagram Methods 0.000 description 12
- 239000000243 solution Substances 0.000 description 11
- 102000013529 alpha-Fetoproteins Human genes 0.000 description 10
- 108010026331 alpha-Fetoproteins Proteins 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 230000009471 action Effects 0.000 description 5
- 230000000875 corresponding effect Effects 0.000 description 5
- 230000008105 immune reaction Effects 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- 239000000427 antigen Substances 0.000 description 4
- 244000052616 bacterial pathogen Species 0.000 description 4
- 230000002596 correlated effect Effects 0.000 description 4
- 238000003018 immunoassay Methods 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 230000001605 fetal effect Effects 0.000 description 3
- 230000005484 gravity Effects 0.000 description 3
- 241000711404 Avian avulavirus 1 Species 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 102000027450 oncoproteins Human genes 0.000 description 2
- 108091008819 oncoproteins Proteins 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 1
- 239000007987 MES buffer Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 244000000005 bacterial plant pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000005389 magnetism Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 235000021485 packed food Nutrition 0.000 description 1
- 238000003380 quartz crystal microbalance Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 238000011896 sensitive detection Methods 0.000 description 1
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 238000007794 visualization technique Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54346—Nanoparticles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6875—Nucleoproteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Nanotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
本发明涉及一种检测生物大分子或微生物体的方法。所述方法包括如下步骤:使用生物大分子或微生物体的抗体包被的单分散超顺纳米磁珠与待检测样品接触进行孵育反应,生成多颗粒的超顺纳米磁珠团簇;反应后进行磁分离得到聚集物,根据所述聚集物的聚集程度确定待检测样品中生物大分子或微生物体的浓度。本发明的方法将免疫磁富集与可视化检测集于一体,操作简单,整个检测过程所需时间短,不需要特殊的仪器设备,而且本发明的方法对抗体的纯度要求不高,可以大大降低检测成本。
The invention relates to a method for detecting biological macromolecules or microorganisms. The method comprises the steps of: using biomacromolecule or microbial antibody-coated monodisperse superparamagnetic nano-magnetic beads to contact with the sample to be detected for incubation reaction to generate multi-particle superparamagnetic nano-magnetic bead clusters; Aggregates are obtained through magnetic separation, and the concentration of biological macromolecules or microorganisms in the sample to be detected is determined according to the degree of aggregation of the aggregates. The method of the present invention integrates immunomagnetic enrichment and visual detection, is simple to operate, takes a short time for the entire detection process, does not require special equipment, and the method of the present invention does not require high purity of antibodies, which can greatly reduce Testing costs.
Description
技术领域technical field
本发明涉及免疫检测分析技术领域,尤其涉及一种快速、灵敏和低成本的可视化检测生物大分子或微生物体的方法。The invention relates to the technical field of immunoassay analysis, in particular to a fast, sensitive and low-cost method for visually detecting biological macromolecules or microorganisms.
背景技术Background technique
传染性动植物致病菌、病毒以及临床样品中的蛋白质等生物标志物的快速、灵敏、低成本的检测和诊断对保护人类健康及生命安全、保障环境和国家安全、维护社会稳定具有重要意义。目前比较成熟的检测方法主要包括分离培养检测、免疫学检测和分子生物学等方法。分离培养方法简单、易行,但由于其检测灵敏度低、耗时长,无法达到现场、快速的要求。免疫学方法主要包括酶联免疫分析和免疫层析试纸条的方法,酶联免疫方法具有简单、灵敏度比较高、成本低等优点,适合于大规模样品筛查,但其需要多步洗涤,比较耗时耗力,因此其使用也受到一定的限制。胶体金免疫层析试纸条具有快速、简单、低成本等优点,但其灵敏度相对比较低,不能实现定量检测。分子生物学方法主要是基于PCR的分析方法,具有检测灵敏度高,特异性好等优点,但需要昂贵的仪器和较高的专业技术人员操作,其应用受到一定的限制。因此,构建一种适合现场、快速、高灵敏和个性化诊断的分析方法,实现对环境、食品和生物样品中致病菌、病毒和蛋白质的检测具有重要的意义。Rapid, sensitive, and low-cost detection and diagnosis of infectious animal and plant pathogenic bacteria, viruses, and proteins in clinical samples are of great significance to the protection of human health and life safety, the protection of the environment and national security, and the maintenance of social stability . At present, relatively mature detection methods mainly include methods such as isolation and culture detection, immunological detection and molecular biology. The separation and culture method is simple and easy to implement, but due to its low detection sensitivity and time-consuming, it cannot meet the on-site and rapid requirements. Immunological methods mainly include ELISA and immunochromatographic test strips. ELISA has the advantages of simplicity, high sensitivity, and low cost. It is suitable for large-scale sample screening, but it requires multi-step washing. It is time-consuming and labor-intensive, so its use is also subject to certain restrictions. Colloidal gold immunochromatographic test strips have the advantages of quickness, simplicity, and low cost, but their sensitivity is relatively low and quantitative detection cannot be achieved. Molecular biology methods are mainly PCR-based analysis methods, which have the advantages of high detection sensitivity and good specificity, but require expensive instruments and highly skilled personnel to operate, and their application is limited to a certain extent. Therefore, it is of great significance to construct an analytical method suitable for on-site, rapid, highly sensitive and personalized diagnosis to realize the detection of pathogenic bacteria, viruses and proteins in environmental, food and biological samples.
超顺纳米磁珠具有饱和磁性强、单分散性好、粒径可控和多元颜色等优异的磁学和光学性质,因此基于超顺纳米磁珠的免疫磁性分离技术具有免疫反应的高度特异性和磁性分离的快速、简单和高效的优点,是目前应用最广泛的分离、富集技术,近几年已被广泛地应用于致病菌、病毒、蛋白、肿瘤细胞等生物大分子或微生物体的分离和富集。在免疫磁富集反应中,免疫磁珠和目标物的识别是在悬浮溶液中进行的,是一种均相的免疫反应模式,有利于抗体-抗原的充分反应,可以加快反应的速度,因此可以与其它很多技术结合起来,构建一系列新型的分析方法,例如磁分离-荧光免疫分析方法、磁分离-化学发光分析方法、富集-微流控芯片技术、磁分离-表面等离子共振生物传感器、磁富集-石英晶微天平生物传感器等方法。由于免疫磁分离技术的发展,大大促进了相关分析技术的发展,其应用潜力正在不断地发掘出来。Superparamagnetic nano-magnetic beads have excellent magnetic and optical properties such as strong saturation magnetism, good monodispersity, controllable particle size and multiple colors, so the immunomagnetic separation technology based on superparamagnetic nano-magnetic beads has a high specificity of immune response It is the most widely used separation and enrichment technology due to its fast, simple and efficient advantages of magnetic separation. In recent years, it has been widely used in biological macromolecules or microorganisms such as pathogenic bacteria, viruses, proteins, and tumor cells. separation and enrichment. In the immunomagnetic enrichment reaction, the recognition of the immunomagnetic beads and the target is carried out in a suspension solution, which is a homogeneous immune reaction mode, which is conducive to the full reaction of the antibody-antigen and can speed up the reaction. Therefore, It can be combined with many other technologies to construct a series of new analysis methods, such as magnetic separation-fluorescence immunoassay, magnetic separation-chemiluminescence analysis, enrichment-microfluidic chip technology, magnetic separation-surface plasmon resonance biosensor , Magnetic enrichment-quartz crystal microbalance biosensor and other methods. Due to the development of immunomagnetic separation technology, the development of related analysis technology has been greatly promoted, and its application potential is constantly being explored.
发明内容Contents of the invention
针对现有技术的不足,我们对免疫磁珠检测进行深入研究,发现通过免疫反应形成的多颗粒的超顺纳米磁珠团簇与单分散超顺纳米磁珠在磁场中的聚集状态不同,并且免疫超顺纳米磁珠的聚集程度与样品中的目标物的含量呈正相关性。Aiming at the deficiencies of the existing technology, we conducted an in-depth study on the detection of immunomagnetic beads, and found that the aggregation state of multi-particle superparamagnetic nanomagnetic bead clusters formed by immune reaction is different from that of monodisperse superparamagnetic nanomagnetic beads in a magnetic field, and The degree of aggregation of the immunosupercisive nanomagnetic beads is positively correlated with the content of the target in the sample.
因此,本发明的目的在于提供一种快速、灵敏和低成本的可视化检测生物大分子或微生物体的方法,所述方法中免疫超顺纳米磁珠既作为磁分离、富集的载体;同时由于其具有颜色,并且多颗粒的超顺纳米磁珠团簇与单分散超顺纳米磁珠在磁场中聚集程度不同,可作为可视化的信号报告标志,将免疫反应中的磁分离、富集和检测集于一步完成,实现对样品中目标物的快速、灵敏地检测。Therefore, the object of the present invention is to provide a kind of fast, sensitive and low-cost method for visually detecting biomacromolecules or microorganisms, in the described method, immunosuperparamagnetic nano-magnetic beads are both used as magnetic separation and enrichment carriers; It has color, and multi-particle superparamagnetic nanomagnetic bead clusters are different from monodisperse superparamagnetic nanomagnetic beads in the magnetic field. It can be used as a visual signal reporting mark, and the magnetic separation, enrichment and detection in the immune reaction It is completed in one step to realize the rapid and sensitive detection of the target in the sample.
为实现本发明的目的,本发明提供以下技术方案:For realizing the purpose of the present invention, the present invention provides following technical scheme:
一种检测生物大分子或微生物体的方法,包括如下步骤:使用生物大分子或微生物体的抗体包被的单分散超顺纳米磁珠与待检测样品接触进行孵育反应,生成多颗粒的超顺纳米磁珠团簇;反应后进行磁分离得到聚集物,根据所述聚集物的聚集程度确定待检测样品中生物大分子或微生物体的浓度。A method for detecting biomacromolecules or microorganisms, comprising the following steps: using monodisperse superparamagnetic nano-magnetic beads coated with antibodies of biomacromolecules or microorganisms to contact with a sample to be detected for incubation and reaction to generate multi-particle superparamagnetic Nano-magnetic bead clusters; magnetic separation is performed after the reaction to obtain aggregates, and the concentration of biomacromolecules or microorganisms in the sample to be detected is determined according to the degree of aggregation of the aggregates.
在超顺纳米磁珠的表面偶联上相应生物大分子或微生物体的抗体,制备成免疫超顺纳米磁珠。在免疫反应中,生物大分子或微生物体具有多个抗原决定簇,通过抗体-抗原之间的特异性识别,可以连接多个单分散性的免疫超顺纳米磁珠。单分散性的免疫超顺纳米磁珠通过这种抗原的“桥梁”连接作用,变成团簇状的多颗粒的超顺纳米磁珠团簇。然后在外加磁场的作用下,变成聚集态的多颗粒超顺纳米磁珠团簇(聚集物),由于单分散超顺纳米磁珠与聚集的多颗粒超顺纳米磁珠在磁场中的分散状态不同,导致聚集程度不同,并且单分散性的免疫超顺纳米磁珠的聚集程度与样品中目标物(生物大分子或微生物体)的含量正相关,基于此,可以根据聚集物的聚集程度确定待检测样品中生物大分子或微生物体的浓度,从而构建检测生物大分子或微生物体的可视化分析方法。Antibodies of corresponding biomacromolecules or microorganisms are coupled on the surface of superparamagnetic nano-magnetic beads to prepare immune superparamagnetic nano-magnetic beads. In the immune response, biological macromolecules or microorganisms have multiple antigenic determinants, and through the specific recognition between antibodies and antigens, multiple monodisperse immune superparamagnetic nanomagnetic beads can be connected. The monodisperse immune superparamagnetic nano-magnetic beads become clustered multi-particle superparamagnetic nano-magnetic bead clusters through the "bridge" connection of the antigen. Then under the action of an external magnetic field, it becomes an aggregated multi-particle superparametric nanomagnetic bead cluster (aggregation), due to the dispersion of the monodisperse superparamagnetic nanomagnetic beads and the aggregated multiparticle superparamagnetic nanomagnetic beads in the magnetic field Different states lead to different degrees of aggregation, and the degree of aggregation of monodisperse immunosuperparamagnetic nano-magnetic beads is positively correlated with the content of target objects (biological macromolecules or microorganisms) in the sample. Based on this, the degree of aggregation of aggregates can be Determine the concentration of biomacromolecules or microorganisms in the sample to be detected, so as to construct a visual analysis method for detecting biomacromolecules or microorganisms.
作为本发明的优选方案,所述聚集物的聚集程度与所述生物大分子或微生物体的浓度呈正相关。所述生物大分子或微生物体的浓度越高,则所述聚集物的颜色越深;因此可以预先使用标准样品构建生物大分子或微生物体的浓度与聚集物的聚集程度之间的曲线关系图,根据该曲线关系图可以确定一个特定颜色深度所对应的生物大分子或微生物体的浓度,实现样品中生物大分子或微生物体的浓度定量确定。As a preferred solution of the present invention, the aggregation degree of the aggregate is positively correlated with the concentration of the biomacromolecule or microorganism. The higher the concentration of the biomacromolecule or microorganism, the darker the color of the aggregate; therefore, standard samples can be used in advance to construct a curve relationship between the concentration of the biomacromolecule or microorganism and the degree of aggregation of the aggregate According to the graph, the concentration of biomacromolecules or microorganisms corresponding to a specific color depth can be determined, and the quantitative determination of the concentration of biomacromolecules or microorganisms in the sample can be realized.
作为本发明的优选方案,所述生物大分子包括蛋白质、核酸和多糖,优选蛋白质。由于蛋白质、核酸和多糖都可能有相应的抗原表位,供相应抗体结合,实现多颗粒的超顺纳米磁珠团簇的生成,因此均可作为本发明的生物大分子检测对象。As a preferred solution of the present invention, the biomacromolecule includes protein, nucleic acid and polysaccharide, preferably protein. Since proteins, nucleic acids and polysaccharides may have corresponding epitopes for the binding of corresponding antibodies to realize the generation of multi-particle superparamagnetic nano-magnetic bead clusters, they can all be used as the detection objects of biological macromolecules in the present invention.
优选地,所述蛋白质包括脂蛋白、糖蛋白、核蛋白和生物标志物。Preferably, said proteins include lipoproteins, glycoproteins, nucleoproteins and biomarkers.
作为本发明的优选方案,所述微生物体包括细菌、真菌和病毒。由于细菌、真菌和病毒表面的蛋白具有抗原表位,能够与相应抗体结合,实现多颗粒的超顺纳米磁珠团簇的生成,因此均可作为本发明的微生物体检测对象。上述微生物体可以是致病菌或非致病菌,但是本发明排除疾病诊断的情况。As a preferred solution of the present invention, the microorganisms include bacteria, fungi and viruses. Since the proteins on the surface of bacteria, fungi and viruses have antigenic epitopes, which can be combined with corresponding antibodies to realize the generation of multi-particle superparamagnetic nano-magnetic bead clusters, they can all be used as the detection objects of microorganisms in the present invention. The aforementioned microorganisms may be pathogenic bacteria or non-pathogenic bacteria, but the present invention excludes the case of disease diagnosis.
作为本发明的优选方案,所述待检测样品为环境、生物或食品来源的样品。来源于环境的样品比如可以是来源于污染水体的样品,其中含有待检测的生物大分子或微生物体,通过使用本发明的方法,对这些物质进行定量,实现污染状况的评估。来源于食品的样品比如可以是来源于人工加工的熟食或包装食品的样品,其中含有待检测的生物大分子或微生物体,通过使用本发明的方法,对这些物质进行定量,实现食品安全评估。As a preferred solution of the present invention, the sample to be detected is a sample of environmental, biological or food origin. The samples from the environment can be, for example, samples from polluted water bodies, which contain biological macromolecules or microorganisms to be detected. By using the method of the present invention, these substances can be quantified to realize the assessment of the pollution status. Samples derived from food can be, for example, samples derived from artificially processed cooked food or packaged food, which contain biomacromolecules or microorganisms to be detected. By using the method of the present invention, these substances are quantified to achieve food safety assessment.
作为本发明的优选方案,所述抗体为单克隆抗体和/或多克隆抗体,优选多克隆抗体。由于待检测样品中的生物大分子或微生物体表面可能具有多个抗原决定簇,在有相同或相似抗原决定簇的情况下使用单克隆抗体也能够实现“桥梁”连接作用;多克隆抗体由于具有各种抗原决定簇的结合位点,能够很容易实现“桥梁”连接作用。毫无疑问,本发明也可以使用单克隆抗体和多克隆抗体的混合,并且本发明对单克隆抗体的纯度要求不高,即使含有杂质,对于本发明的影响也可以忽略。As a preferred solution of the present invention, the antibody is a monoclonal antibody and/or a polyclonal antibody, preferably a polyclonal antibody. Since there may be multiple antigenic determinants on the surface of biological macromolecules or microorganisms in the sample to be detected, the use of monoclonal antibodies can also achieve "bridge" connection in the case of the same or similar antigenic determinants; polyclonal antibodies have The binding sites of various antigenic determinants can easily realize the role of "bridge" connection. Undoubtedly, the present invention can also use a mixture of monoclonal antibodies and polyclonal antibodies, and the present invention does not require high purity of monoclonal antibodies, even if it contains impurities, the impact on the present invention can be ignored.
作为本发明的优选方案,所述生物大分子或微生物体具有多个抗原决定簇。同一生物大分子或微生物体的多个抗原决定簇分别与不同免疫超顺纳米磁珠表面的抗体结合,实现“桥梁”连接作用,生成超顺纳米磁珠团簇。As a preferred solution of the present invention, the biomacromolecule or microorganism has multiple antigenic determinants. Multiple antigenic determinants of the same biomacromolecule or microorganism are combined with antibodies on the surface of different immune superparamagnetic nano-magnetic beads to realize the "bridge" connection and generate superparamagnetic nano-magnetic bead clusters.
作为本发明的优选方案,所述孵育反应时间为5-60min,例如5min、6min、10min、12min、15min、20min、25min、30min、40min、45min、50min、55min、58min、10-40min、10-30min、5-20min、15-30min,优选15min。As a preferred version of the present invention, the incubation reaction time is 5-60min, such as 5min, 6min, 10min, 12min, 15min, 20min, 25min, 30min, 40min, 45min, 50min, 55min, 58min, 10-40min, 10- 30min, 5-20min, 15-30min, preferably 15min.
作为本发明的优选方案,所述磁分离的时间为0.5-5min,例如0.5min、1min、1.5min、2min、2.5min、3min、4min、4.5min、4.8min,优选1min。As a preferred solution of the present invention, the magnetic separation time is 0.5-5 min, such as 0.5 min, 1 min, 1.5 min, 2 min, 2.5 min, 3 min, 4 min, 4.5 min, 4.8 min, preferably 1 min.
作为本发明的优选方案,根据所述聚集物的聚集程度确定待检测样品中生物大分子或微生物体的浓度,具体为:As a preferred solution of the present invention, the concentration of biological macromolecules or microorganisms in the sample to be detected is determined according to the degree of aggregation of the aggregates, specifically:
获取所述聚集物的照片,通过对照片灰度值进行定量来确定待检测样品中生物大分子或微生物体的浓度。A photo of the aggregate is obtained, and the concentration of the biomacromolecule or microorganism in the sample to be detected is determined by quantifying the gray value of the photo.
相比现有技术,本发明的有益效果为:Compared with the prior art, the beneficial effects of the present invention are:
本发明的检测生物大分子或微生物体的方法,基于超顺纳米磁珠的优异磁学和光学性能,将免疫磁富集与可视化检测集于一体,操作简单,整个检测过程所需时间短,不需要特殊的仪器设备,只需要一种抗体,避免了传统的免疫检测对两种抗体(捕获抗体和检测抗体)的需要,而且本发明的方法对抗体的纯度要求不高,可以大大降低检测成本。此外,本发明的方法具有普遍适用性,可以检测细菌、真菌、病毒和蛋白质等,适合现场检测,具有很大的应用前景。The method for detecting biological macromolecules or microorganisms of the present invention is based on the excellent magnetic and optical properties of superparamagnetic nano-magnetic beads, integrates immunomagnetic enrichment and visual detection, is simple to operate, and takes a short time for the entire detection process. No special equipment is needed, only one type of antibody is needed, which avoids the need for two types of antibodies (capture antibody and detection antibody) in traditional immunoassays, and the method of the present invention does not require high purity of antibodies, which can greatly reduce the detection time. cost. In addition, the method of the present invention has universal applicability, can detect bacteria, fungi, viruses, proteins, etc., is suitable for on-site detection, and has great application prospects.
附图说明Description of drawings
图1为本发明的基于免疫超顺纳米磁珠聚集的可视化方法检测生物大分子或微生物体的反应原理示意图。其中,(1)表示单分散免疫超顺纳米磁珠与样品中的生物大分子或微生物体之间的免疫反应;(2)表示通过抗原的“桥梁”作用形成的多颗粒的免疫超顺纳米磁珠团簇;(3)表示多颗粒的免疫超顺纳米磁珠团簇在外加磁场的作用下,形成聚集的免疫超顺纳米磁珠聚集物;样品中目标物(生物大分子或微生物体)越多,免疫超顺纳米磁珠的聚集程度就越大,其颜色就越深。Fig. 1 is a schematic diagram of the reaction principle of the detection of biological macromolecules or microorganisms by the visualization method based on the aggregation of immunosupercisive nano-magnetic beads of the present invention. Among them, (1) represents the immune reaction between monodisperse immunosupercisive nano magnetic beads and biomacromolecules or microorganisms in the sample; Magnetic bead cluster; (3) the immunosuperparamagnetic nanomagnetic bead cluster that expresses multiparticle is under the effect of applied magnetic field, forms the immunosuperparamagnetic nanomagnetic bead aggregate of aggregation; Target (biological macromolecule or microbial body ) more, the greater the degree of aggregation of the immunosupercisive nano-magnetic beads, and the darker its color.
图2为本发明的免疫超顺纳米磁珠磁聚集的机理图。其中,(a)表示免疫超顺纳米磁珠与样品混合在一起,反应15min之后,没有外加磁场下的状态图;(b)表示免疫超顺纳米磁珠与样品混合在一起,反应15min之后,在磁场下的状态图;(c)表示将外加磁场去掉,将聚集状态的免疫超顺纳米磁珠重悬,然后放在没有外加磁场的试管架上,所述免疫超顺纳米磁珠在重力单独作用下的状态图。数字表示生物大分子或微生物体的浓度(cfu/mL)。Fig. 2 is a mechanism diagram of the magnetic aggregation of the immunosuperparamagnetic nano magnetic beads of the present invention. Among them, (a) shows that the immune superparamagnetic nano-magnetic beads are mixed with the sample, and after reacting for 15 minutes, there is no state diagram under an external magnetic field; The state diagram under the magnetic field; (c) represents that the external magnetic field is removed, the immunosuperparamagnetic nano-magnetic beads in the aggregated state are resuspended, and then placed on a test tube rack without an external magnetic field, and the immune superparamagnetic nano-magnetic beads are under gravity A state diagram for a single action. Numbers indicate the concentration (cfu/mL) of biomacromolecules or microorganisms.
图3为本发明的方法检测大肠杆菌的结果图。其中,(a)表示免疫超顺纳米磁珠与大肠杆菌样品混合在一起,反应之后,在磁场下的状态图;样品中大肠杆菌浓度(cfu/mL)越高,免疫超顺纳米磁珠的聚集程度就越大,其颜色就越深;(b)表示聚集物照片灰度值与样品中大肠杆菌浓度梯度(图中1-6分别表示大肠杆菌浓度107、106、105、104、103、0cfu/mL)的关系图;大肠杆菌浓度越高,灰度值越大。Fig. 3 is a graph showing the results of detection of Escherichia coli by the method of the present invention. Among them, (a) represents the state diagram of immune superparamagnetic nano-magnetic beads mixed with Escherichia coli sample after the reaction under a magnetic field; The greater the degree of aggregation, the darker its color; (b) represents the gray value of the photo of the aggregate and the concentration gradient of E. coli in the sample (1-6 in the figure respectively represent the concentration of E. coli 10 7 , 10 6 , 10 5 , 10 4 , 10 3 , 0cfu/mL); the higher the concentration of Escherichia coli, the larger the gray value.
图4为本发明的方法检测胎癌蛋白(CEA)的结果图。其中,(a)表示免疫超顺纳米磁珠与CEA样品混合在一起,反应之后,在磁场下的状态图;样品中CEA浓度(ng/mL)越高,免疫超顺纳米磁珠的聚集程度就越大,其颜色就越深;(b)表示聚集物照片灰度值与样品中CEA浓度(ng/mL)的关系图;CEA浓度越高,灰度值越大。Fig. 4 is a graph showing the results of detection of fetal oncoprotein (CEA) by the method of the present invention. Wherein, (a) represents the immunosuperparamagnetic nano-magnetic beads mixed with the CEA sample, after the reaction, the state diagram under the magnetic field; The bigger it is, the darker its color is; (b) shows the relationship between the gray value of aggregate photos and the concentration of CEA in the sample (ng/mL); the higher the concentration of CEA, the larger the gray value.
图5为本发明的方法检测甲胎蛋白(AFP)的结果图。其中1-6分别表示AFP浓度分别为40、20、10、5、2.5和0ng/mL的样品与免疫超顺纳米磁珠混合在一起,反应之后,在磁场下的状态图;样品中AFP浓度(ng/mL)越高,免疫超顺纳米磁珠的聚集程度就越大,其颜色就越深。Fig. 5 is a graph showing the results of detection of alpha-fetoprotein (AFP) by the method of the present invention. Among them, 1-6 respectively represent the state diagram under the magnetic field after the samples with AFP concentration of 40, 20, 10, 5, 2.5 and 0ng/mL are mixed with the immunosuperparamagnetic nano-magnetic beads; the concentration of AFP in the sample The higher the (ng/mL), the greater the degree of aggregation of the immunosuperparamagnetic nano-magnetic beads, and the darker its color.
具体实施方式Detailed ways
下面将结合实施例对本发明的实施方案进行详细描述。本领域技术人员将会理解,以下实施例仅为本发明的优选实施例,以便于更好地理解本发明,因而不应视为限定本发明的范围。Embodiments of the present invention will be described in detail below in conjunction with examples. Those skilled in the art will understand that the following examples are only preferred examples of the present invention, so as to better understand the present invention, and thus should not be considered as limiting the scope of the present invention.
下述实施例中的实验方法,如无特殊说明,均为常规方法;所用的实验材料,如无特殊说明,均为自常规生化试剂厂商购买得到的。The experimental methods in the following examples, unless otherwise specified, are conventional methods; the experimental materials used, unless otherwise specified, were purchased from conventional biochemical reagent manufacturers.
本发明的反应原理示意图如图1所示,(1)表示单分散免疫超顺纳米磁珠与样品中的生物大分子或微生物体之间的免疫反应;(2)表示通过抗原的“桥梁”作用形成的多颗粒的免疫超顺纳米磁珠团簇;(3)表示多颗粒的免疫超顺纳米磁珠团簇在外加磁场的作用下,形成聚集的免疫超顺纳米磁珠聚集物;样品中目标物(生物大分子或微生物体)越多,免疫超顺纳米磁珠的聚集程度就越大,其颜色就越深。The schematic diagram of the reaction principle of the present invention is as shown in Figure 1, (1) represents the immune reaction between the monodisperse immune super-parallel nano-magnetic beads and the biological macromolecules or microorganisms in the sample; (2) represents the "bridge" through the antigen The multi-particle immunosuperparamagnetic nano-magnetic bead cluster formed by the interaction; (3) means that the multi-particle immunosuperparamagnetic nano-magnetic bead cluster forms an aggregated immunosuperparamagnetic nano-magnetic bead aggregate under the action of an external magnetic field; the sample The more targets (biological macromolecules or microorganisms) in the medium, the greater the aggregation degree of the immunosuperparamagnetic nano-magnetic beads, and the darker the color.
下列实施例中所用的试剂仪器设备来源如下:大肠杆菌购自美国菌种保存中心,大肠杆菌抗体(多抗)购自美国Genway;甲胎蛋白、胎癌蛋白及其相关抗体购自北京热景生物技术有限公司;磁分离架购自上海奥润微纳新材料有限公司;涡流振荡器购自德国IKA公司。The sources of reagents, instruments and equipment used in the following examples are as follows: Escherichia coli was purchased from American Culture Collection Center, Escherichia coli antibody (polyclonal antibody) was purchased from Genway, USA; alpha-fetoprotein, fetal oncoprotein and related antibodies were purchased from Beijing Rejing Biotechnology Co., Ltd.; the magnetic separation frame was purchased from Shanghai Aorun Micro-Nano New Material Co., Ltd.; the eddy current oscillator was purchased from IKA, Germany.
实施例1Example 1
免疫超顺纳米磁珠的制备和磁聚集可视化免疫检测,具体步骤如下:The preparation of immunosuperparamagnetic nano-magnetic beads and the visual immunodetection of magnetic aggregation, the specific steps are as follows:
(1)免疫超顺纳米磁珠的制备:(1) Preparation of immunosupercisive nano-magnetic beads:
将一定量的表面修饰有羧基的超顺纳米磁珠(0.2-0.5mg)分散在一定体积的MES缓冲溶液中(pH=5.6,0.01M),然后加入一定量的碳二亚胺(EDC,0.01-0.1mg)和N-羟基琥珀酰亚胺(NHS,0.01-0.1mg),在涡流振荡器上轻轻地振荡反应0.5h,然后磁分离,再用pH=7.4的PBS缓冲液重悬,然后加入一定量的抗体(0.1-0.5mg),反应2h,再加入5%BSA(100-500μL)反应0.5h,最后磁分离,去掉上清液,然后加入一定量的PBST洗涤液重悬超顺纳米磁珠,然后再磁分离,去掉上清液,重复洗3次,最后得到的免疫超顺纳米磁珠,用PBS缓冲液重悬,在4℃冰箱保存。Disperse a certain amount of superparamagnetic nano-magnetic beads (0.2-0.5mg) modified with carboxyl groups on the surface in a certain volume of MES buffer solution (pH=5.6, 0.01M), and then add a certain amount of carbodiimide (EDC, 0.01-0.1mg) and N-hydroxysuccinimide (NHS, 0.01-0.1mg), gently shake the reaction on a vortex shaker for 0.5h, then magnetically separate, and resuspend with PBS buffer at pH=7.4 , then add a certain amount of antibody (0.1-0.5mg), react for 2h, then add 5% BSA (100-500μL) for 0.5h, finally magnetically separate, remove the supernatant, then add a certain amount of PBST washing solution to resuspend The superparamagnetic nano-magnetic beads were then magnetically separated, the supernatant was removed, and the wash was repeated 3 times. The finally obtained immune superparamagnetic nano-magnetic beads were resuspended in PBS buffer and stored in a refrigerator at 4°C.
(2)磁聚集可视化免疫检测步骤:(2) Magnetic aggregation visualization immunoassay steps:
将一定量的免疫超顺纳米磁珠和一系列浓度的生物大分子(如蛋白质)或微生物体(如细菌、真菌或病毒)混合在一起,在振荡器上反应10-20min,然后将装有免疫超顺纳米磁珠的试管放在磁分离架上,1min后观察免疫超顺纳米磁珠的聚集状态。Mix a certain amount of immunosupercisive nanomagnetic beads with a series of concentrations of biomacromolecules (such as proteins) or microorganisms (such as bacteria, fungi or viruses), react on a shaker for 10-20min, and then put the The test tube of the immunosuperparamagnetic nano-magnetic beads is placed on the magnetic separation rack, and the aggregation state of the immuno-superparamagnetic nano-magnetic beads is observed after 1 min.
上述步骤之后的结果如图2所示,(a)表示免疫超顺纳米磁珠与样品混合在一起,反应15min之后,没有外加磁场下的状态图;(b)表示免疫超顺纳米磁珠与样品混合在一起,反应15min之后,在磁场下的状态图;(c)表示将外加磁场去掉,将聚集状态的免疫超顺纳米磁珠重悬,然后放在没有外加磁场的试管架上,所述免疫超顺纳米磁珠在重力单独作用下的状态图。可见,样品中目标物(如大肠杆菌)越多,免疫超顺纳米磁珠的聚集程度就越大,其颜色就越深;重悬后,在重力单独作用下的沉降速度和程度越大。The results after the above steps are shown in Figure 2, (a) shows that the immunosuperparamagnetic nano-magnetic beads are mixed with the sample, and after reacting for 15 minutes, there is no state diagram under an external magnetic field; (b) shows that the immunosuperparamagnetic nano-magnetic beads and The samples are mixed together and reacted for 15 minutes, the state diagram under the magnetic field; (c) shows that the external magnetic field is removed, the immunosuperparamagnetic nano-magnetic beads in the aggregated state are resuspended, and then placed on the test tube rack without the external magnetic field. The state diagram of the above-mentioned immunosuperparamagnetic nano-magnetic beads under the action of gravity alone. It can be seen that the more target substances (such as Escherichia coli) in the sample, the greater the degree of aggregation of the immunosupercisive nano-magnetic beads, and the darker their color; after resuspension, the greater the sedimentation speed and degree under the action of gravity alone.
实施例2Example 2
检测水样中的大肠杆菌,具体实验步骤如下:To detect Escherichia coli in water samples, the specific experimental steps are as follows:
(1)将一系列不同浓度的大肠杆菌(107、106、105、104、103和0cfu/mL)各900μL和一定量的超顺纳米磁珠(100μL)混合在一起,在涡流振荡器上振荡反应15min;(1) Mix a series of different concentrations of Escherichia coli (10 7 , 10 6 , 10 5 , 10 4 , 10 3 and 0 cfu/mL) each in 900 μL and a certain amount of superparamagnetic nano-magnetic beads (100 μL), Shake the reaction on a vortex shaker for 15 minutes;
(2)将上述反应完的免疫混合物放在磁分离架上,磁分离1min;(2) Place the above-mentioned reacted immune mixture on a magnetic separation rack, and magnetically separate for 1 min;
(3)肉眼观察超顺纳米磁珠的状态,可见样品中大肠杆菌浓度(cfu/mL)越高,免疫超顺纳米磁珠的聚集程度就越大,其颜色就越深(图3a);用相机拍照,并用相关的图形处理软件对其灰度值进行定量,结果显示:大肠杆菌浓度越高,灰度值越大(图3b)。(3) Observing the state of the superparamagnetic nano-magnetic beads with naked eyes, it can be seen that the higher the concentration of Escherichia coli (cfu/mL) in the sample, the greater the aggregation degree of the immune superparamagnetic nano-magnetic beads, and the darker its color (Figure 3a); Take photos with a camera, and use relevant graphics processing software to quantify the gray value. The results show that the higher the concentration of E. coli, the larger the gray value (Fig. 3b).
实施例3Example 3
检测鸡胚囊液中的新城疫病毒,具体实验步骤如下:To detect Newcastle disease virus in chicken embryo sac fluid, the specific experimental steps are as follows:
(1)将一系列不同浓度的新城疫病毒(107、106、105、104、103和0copy/mL)各900μL和一定量的超顺纳米磁珠(100μL)混合在一起,在涡流振荡器上振荡反应15min;(1) Mix 900 μL each of a series of different concentrations of Newcastle disease virus (10 7 , 10 6 , 10 5 , 10 4 , 10 3 and 0 copy/mL) and a certain amount of superparamagnetic nano-magnetic beads (100 μL), Shake the reaction on a vortex shaker for 15 minutes;
(2)将上述反应完的免疫混合物放在磁分离架上,磁分离1min;(2) Place the above-mentioned reacted immune mixture on a magnetic separation rack, and magnetically separate for 1 min;
(3)肉眼观察超顺纳米磁珠的状态,用相机拍照,并用相关的图形处理软件对其灰度值进行定量。结果类似于图3。(3) Observe the state of the superparamagnetic nano-magnetic beads with naked eyes, take pictures with a camera, and quantify its gray value with relevant graphics processing software. The result is similar to Figure 3.
实施例4Example 4
检测尿液中的胎癌蛋白(CEA)的含量,具体实验步骤如下:Detect the content of fetal cancer protein (CEA) in the urine, the specific experimental steps are as follows:
(1)将一系列不同浓度的CEA(20、10、5、2、1、0ng/mL)各900μL和一定量的超顺纳米磁珠(100μL)混合在一起,在涡流振荡器上振荡反应15min;(1) Mix a series of different concentrations of CEA (20, 10, 5, 2, 1, 0 ng/mL) each 900 μL and a certain amount of superparamagnetic nano-magnetic beads (100 μL), and shake the reaction on a vortex shaker 15min;
(2)将上述反应完的免疫混合物放在磁分离架上,磁分离1min;(2) Place the above-mentioned reacted immune mixture on a magnetic separation rack, and magnetically separate for 1 min;
(3)肉眼观察超顺纳米磁珠的状态,可见样品中CEA浓度(ng/mL)越高,免疫超顺纳米磁珠的聚集程度就越大,其颜色就越深(图4a);用相机拍照,并用相关的图形处理软件对其灰度值进行定量,结果显示:CEA浓度越高,灰度值越大(图4b)。(3) Observing the state of the superparamagnetic nano-magnetic beads with the naked eye, it can be seen that the higher the concentration of CEA (ng/mL) in the sample, the greater the aggregation degree of the immune superparamagnetic nano-magnetic beads, and the darker the color (Fig. 4a); The camera took pictures, and the gray value was quantified with relevant graphics processing software. The results showed that the higher the concentration of CEA, the larger the gray value (Fig. 4b).
实施例5Example 5
检测尿液中的甲胎蛋白(AFP)的含量,具体实验步骤如下:To detect the content of alpha-fetoprotein (AFP) in urine, the specific experimental steps are as follows:
(1)将一系列不同浓度的AFP(40、20、10、5、2.5和0ng/mL)各900μL和一定量的超顺纳米磁珠(100μL)混合在一起,在涡流振荡器上振荡反应15min;(1) Mix a series of different concentrations of AFP (40, 20, 10, 5, 2.5, and 0 ng/mL) with 900 μL each and a certain amount of superparamagnetic nano-magnetic beads (100 μL), and shake the reaction on a vortex shaker 15min;
(2)将上述反应完的免疫混合物放在磁分离架上,磁分离1min;(2) Place the above-mentioned reacted immune mixture on a magnetic separation rack, and magnetically separate for 1 min;
(3)肉眼观察超顺纳米磁珠的状态,样品中AFP浓度(ng/mL)越高,免疫超顺纳米磁珠的聚集程度就越大,其颜色就越深(图5)。用相机拍照,并用相关的图形处理软件对其灰度值进行定量,显示灰度值与AFP浓度呈正相关。(3) Observe the state of the superparamagnetic nano-magnetic beads with the naked eye. The higher the AFP concentration (ng/mL) in the sample, the greater the aggregation degree of the immuno-superparamagnetic nano-magnetic beads, and the darker the color (Figure 5). Take pictures with a camera, and use related graphics processing software to quantify the gray value, which shows that the gray value is positively correlated with the AFP concentration.
申请人声明,本发明通过上述实施例来说明本发明的详细特征以及详细方法,但本发明并不局限于上述详细特征以及详细方法,即不意味着本发明必须依赖上述详细特征以及详细方法才能实施。所属技术领域的技术人员应该明了,对本发明的任何改进,对本发明选用组分的等效替换及辅助成分的添加、具体方式的选择等,均落在本发明的保护范围和公开范围之内。The applicant states that the present invention illustrates the detailed features and detailed methods of the present invention through the above-mentioned embodiments, but the present invention is not limited to the above-mentioned detailed features and detailed methods, that is, it does not mean that the present invention must rely on the above-mentioned detailed features and detailed methods. implement. Those skilled in the art should understand that any improvement of the present invention, equivalent replacement of selected components of the present invention, addition of auxiliary components, selection of specific methods, etc., all fall within the scope of protection and disclosure of the present invention.
Claims (14)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410197209.1A CN103954775B (en) | 2014-05-12 | 2014-05-12 | A kind of method detecting biomacromolecule or microbial body |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410197209.1A CN103954775B (en) | 2014-05-12 | 2014-05-12 | A kind of method detecting biomacromolecule or microbial body |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103954775A CN103954775A (en) | 2014-07-30 |
| CN103954775B true CN103954775B (en) | 2015-08-19 |
Family
ID=51332073
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410197209.1A Expired - Fee Related CN103954775B (en) | 2014-05-12 | 2014-05-12 | A kind of method detecting biomacromolecule or microbial body |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103954775B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104614513B (en) * | 2015-01-26 | 2016-05-25 | 国家纳米科学中心 | A kind of relaxation time immune sensing analytical method separating based on magnetic |
| KR102778662B1 (en) | 2023-04-25 | 2025-03-13 | 주식회사 하울바이오 | Amphiphilic polymer coated magnetic nanocluster and method for detecting exosome or virus using the same |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004092732A1 (en) * | 2003-04-16 | 2004-10-28 | Sekisui Chemical Co., Ltd. | Particle having magnetic material incorporated therein, process for producing the same, particle for immunoassay and method of immunoassay |
| CN101865984A (en) * | 2010-06-03 | 2010-10-20 | 复旦大学 | A magnetic relaxation switch based on Fe3O4@Au and its preparation method |
| CN102323408A (en) * | 2011-05-31 | 2012-01-18 | 上海师范大学 | Method for rapid detection of enterobacter sakazakii |
| CN102426229A (en) * | 2011-09-26 | 2012-04-25 | 广东海洋大学 | Preparation method and application of human IgG immunomagnetic beads for enriching staphylococcus aureus |
| CN103278521A (en) * | 2012-11-30 | 2013-09-04 | 中国检验检疫科学研究院 | Magnetic resonance immune sensing method for detecting biomacromolecule |
| CN103529225A (en) * | 2013-11-04 | 2014-01-22 | 武汉华美生物工程有限公司 | Liver fatty acid binding protein content detection kit and preparation method thereof |
| CN103713134A (en) * | 2013-12-17 | 2014-04-09 | 武汉大学 | Detection kit for visibly detecting virus and virus detection method |
-
2014
- 2014-05-12 CN CN201410197209.1A patent/CN103954775B/en not_active Expired - Fee Related
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004092732A1 (en) * | 2003-04-16 | 2004-10-28 | Sekisui Chemical Co., Ltd. | Particle having magnetic material incorporated therein, process for producing the same, particle for immunoassay and method of immunoassay |
| CN101865984A (en) * | 2010-06-03 | 2010-10-20 | 复旦大学 | A magnetic relaxation switch based on Fe3O4@Au and its preparation method |
| CN102323408A (en) * | 2011-05-31 | 2012-01-18 | 上海师范大学 | Method for rapid detection of enterobacter sakazakii |
| CN102426229A (en) * | 2011-09-26 | 2012-04-25 | 广东海洋大学 | Preparation method and application of human IgG immunomagnetic beads for enriching staphylococcus aureus |
| CN103278521A (en) * | 2012-11-30 | 2013-09-04 | 中国检验检疫科学研究院 | Magnetic resonance immune sensing method for detecting biomacromolecule |
| CN103529225A (en) * | 2013-11-04 | 2014-01-22 | 武汉华美生物工程有限公司 | Liver fatty acid binding protein content detection kit and preparation method thereof |
| CN103713134A (en) * | 2013-12-17 | 2014-04-09 | 武汉大学 | Detection kit for visibly detecting virus and virus detection method |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103954775A (en) | 2014-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104614513B (en) | A kind of relaxation time immune sensing analytical method separating based on magnetic | |
| Zhang et al. | Electrochemical conversion of Fe3O4 magnetic nanoparticles to electroactive Prussian blue analogues for self-sacrificial label biosensing of avian influenza virus H5N1 | |
| CN108982834B (en) | Nanozyme immunosandwich technique for detection of biomolecules | |
| CN102928590A (en) | Kit adopting fluorescent quantum dots to quickly screen, separate and detect salmonella | |
| CN103713134B (en) | A kind of detection kit of Visual retrieval virus and detection method thereof | |
| Smith et al. | Optimization of antibody-conjugated magnetic nanoparticles for target preconcentration and immunoassays | |
| Chiu et al. | An aqueous two-phase system for the concentration and extraction of proteins from the interface for detection using the lateral-flow immunoassay | |
| CN113687063B (en) | Glycoprotein dynamic light scattering immunization method based on phenylboronic acid crosslinking agent | |
| CN103308679A (en) | Method for sensing bacteria through utilizing nanometer fluorescent carbon spot immunolabelling marks | |
| CN101907556A (en) | A method for the detection of Escherichia coli using magnetic nanoparticle enrichment combined with two-color flow cytometry | |
| Zhang et al. | Rapid and sensitive pathogen detection platform based on a lanthanide-labeled immunochromatographic strip test combined with immunomagnetic separation | |
| Zhang et al. | A silicon dioxide modified magnetic nanoparticles–labeled lateral flow strips for HBs antigen | |
| CN103278521A (en) | Magnetic resonance immune sensing method for detecting biomacromolecule | |
| ping Chen et al. | An immunosensor based on magnetic relaxation switch and polystyrene microparticle-induced immune multivalency enrichment system for the detection of Pantoea stewartii subsp. Stewartii | |
| CN107422008B (en) | An electrochemical immunosensor for measuring alpha-fetoprotein and its preparation method and application | |
| CN104374916A (en) | Listeria monocytogenes fluorescence quantitative determination immunochromatography kit | |
| CN115508329B (en) | A method for detecting novel coronavirus N protein based on surface enhanced Raman spectroscopy | |
| CN104749365A (en) | Difunctional composite nanosphere and method for rapidly detecting food-borne pathogenic bacteria | |
| Gabrovska et al. | Immunofluorescent analysis with magnetic nanoparticles for simultaneous determination of antibiotic residues in milk | |
| CN112649602A (en) | Visual kit for detecting staphylococcus aureus based on immunomagnetic beads | |
| Yari et al. | Magnetic particle spectroscopy for point-of-care: A review on recent advances | |
| CN203337668U (en) | Listeria monocytogene immunochromatography kit employing fluorescent quantitative detection | |
| Wu et al. | Wheat Germ Agglutinin‐Modified “Three‐in‐One” Multifunctional Probe Driven Broad‐Spectrum and Flexible Immunochromatographic Diagnosis of viruses With High Sensitivity | |
| Yu et al. | Simultaneous detection of pathogenic bacteria using agglutination test based on colored silica nanoparticles | |
| CN103954775B (en) | A kind of method detecting biomacromolecule or microbial body |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150819 |